Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro

A. Pappalardo, K. Thompson

Research output: Contribution to journalArticle

20 Citations (Scopus)
4 Downloads (Pure)

Abstract

Extensive evidence suggests that the immune system exerts powerful effects on bone cells, particularly in chronic disease pathologies such as rheumatoid arthritis (RA). The chronic inflammatory state in RA, particularly the excessive production of T-cell-derived pro-inflammatory cytokines such as TNF-α and IL-17, triggers bone erosions through the increased stimulation of osteoclast formation and activity. Whilst evidence supports a role for IL-17 and TNF-α secreted by conventional CD4+ T cells in RA, recent evidence in animal models of RA have implicated γδ T cells as a major producer of pathogenic IL-17. However, the capacity of γδ T cells to influence osteoclast formation and activity in humans has not yet been widely investigated. To address this issue we investigated the effects of γδ T cells on osteoclast differentiation and resorptive activity. We have demonstrated that anti-CD3/CD28-stimulated γδ T cells or CD4+ T cells inhibit human osteoclast formation and resorptive activity in vitro. Furthermore, we assessed cytokine production by CD3/CD28-stimulated γδ T cells and observed a lack of IL-17 production, with activated γδ T cells producing abundant IFN-γ. The neutralisation of IFN-γ markedly restored the formation of osteoclasts from precursor cells and the resorptive activity of mature osteoclasts, suggesting IFN-γ is the major factor responsible for the inhibitory role of activated γδ T cells on osteoclastogenesis and resorptive activity of mature osteoclasts. Our work therefore provides new insights on the interactions between γδ T cells and osteoclasts in humans.

Original languageEnglish
Pages (from-to)281-291
Number of pages11
JournalClinical and Experimental Immunology
Volume174
Issue number2
Early online date6 Oct 2013
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Osteoclasts
T-Lymphocytes
Interleukin-17
Rheumatoid Arthritis
In Vitro Techniques
Cytokines
Bone and Bones
Osteogenesis
Human Activities
Immune System
Chronic Disease
Animal Models
Pathology

Keywords

  • CD4+ T cells
  • IFN-γ
  • osteoclast
  • osteoimmunology
  • γδ T cells

Cite this

Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro. / Pappalardo, A.; Thompson, K.

In: Clinical and Experimental Immunology, Vol. 174, No. 2, 11.2013, p. 281-291.

Research output: Contribution to journalArticle

@article{40f67f95ad67415597b447f348da0d91,
title = "Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro",
abstract = "Extensive evidence suggests that the immune system exerts powerful effects on bone cells, particularly in chronic disease pathologies such as rheumatoid arthritis (RA). The chronic inflammatory state in RA, particularly the excessive production of T-cell-derived pro-inflammatory cytokines such as TNF-α and IL-17, triggers bone erosions through the increased stimulation of osteoclast formation and activity. Whilst evidence supports a role for IL-17 and TNF-α secreted by conventional CD4+ T cells in RA, recent evidence in animal models of RA have implicated γδ T cells as a major producer of pathogenic IL-17. However, the capacity of γδ T cells to influence osteoclast formation and activity in humans has not yet been widely investigated. To address this issue we investigated the effects of γδ T cells on osteoclast differentiation and resorptive activity. We have demonstrated that anti-CD3/CD28-stimulated γδ T cells or CD4+ T cells inhibit human osteoclast formation and resorptive activity in vitro. Furthermore, we assessed cytokine production by CD3/CD28-stimulated γδ T cells and observed a lack of IL-17 production, with activated γδ T cells producing abundant IFN-γ. The neutralisation of IFN-γ markedly restored the formation of osteoclasts from precursor cells and the resorptive activity of mature osteoclasts, suggesting IFN-γ is the major factor responsible for the inhibitory role of activated γδ T cells on osteoclastogenesis and resorptive activity of mature osteoclasts. Our work therefore provides new insights on the interactions between γδ T cells and osteoclasts in humans.",
keywords = "CD4+ T cells, IFN-γ, osteoclast, osteoimmunology, γδ T cells",
author = "A. Pappalardo and K. Thompson",
year = "2013",
month = "11",
doi = "10.1111/cei.12165",
language = "English",
volume = "174",
pages = "281--291",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro

AU - Pappalardo, A.

AU - Thompson, K.

PY - 2013/11

Y1 - 2013/11

N2 - Extensive evidence suggests that the immune system exerts powerful effects on bone cells, particularly in chronic disease pathologies such as rheumatoid arthritis (RA). The chronic inflammatory state in RA, particularly the excessive production of T-cell-derived pro-inflammatory cytokines such as TNF-α and IL-17, triggers bone erosions through the increased stimulation of osteoclast formation and activity. Whilst evidence supports a role for IL-17 and TNF-α secreted by conventional CD4+ T cells in RA, recent evidence in animal models of RA have implicated γδ T cells as a major producer of pathogenic IL-17. However, the capacity of γδ T cells to influence osteoclast formation and activity in humans has not yet been widely investigated. To address this issue we investigated the effects of γδ T cells on osteoclast differentiation and resorptive activity. We have demonstrated that anti-CD3/CD28-stimulated γδ T cells or CD4+ T cells inhibit human osteoclast formation and resorptive activity in vitro. Furthermore, we assessed cytokine production by CD3/CD28-stimulated γδ T cells and observed a lack of IL-17 production, with activated γδ T cells producing abundant IFN-γ. The neutralisation of IFN-γ markedly restored the formation of osteoclasts from precursor cells and the resorptive activity of mature osteoclasts, suggesting IFN-γ is the major factor responsible for the inhibitory role of activated γδ T cells on osteoclastogenesis and resorptive activity of mature osteoclasts. Our work therefore provides new insights on the interactions between γδ T cells and osteoclasts in humans.

AB - Extensive evidence suggests that the immune system exerts powerful effects on bone cells, particularly in chronic disease pathologies such as rheumatoid arthritis (RA). The chronic inflammatory state in RA, particularly the excessive production of T-cell-derived pro-inflammatory cytokines such as TNF-α and IL-17, triggers bone erosions through the increased stimulation of osteoclast formation and activity. Whilst evidence supports a role for IL-17 and TNF-α secreted by conventional CD4+ T cells in RA, recent evidence in animal models of RA have implicated γδ T cells as a major producer of pathogenic IL-17. However, the capacity of γδ T cells to influence osteoclast formation and activity in humans has not yet been widely investigated. To address this issue we investigated the effects of γδ T cells on osteoclast differentiation and resorptive activity. We have demonstrated that anti-CD3/CD28-stimulated γδ T cells or CD4+ T cells inhibit human osteoclast formation and resorptive activity in vitro. Furthermore, we assessed cytokine production by CD3/CD28-stimulated γδ T cells and observed a lack of IL-17 production, with activated γδ T cells producing abundant IFN-γ. The neutralisation of IFN-γ markedly restored the formation of osteoclasts from precursor cells and the resorptive activity of mature osteoclasts, suggesting IFN-γ is the major factor responsible for the inhibitory role of activated γδ T cells on osteoclastogenesis and resorptive activity of mature osteoclasts. Our work therefore provides new insights on the interactions between γδ T cells and osteoclasts in humans.

KW - CD4+ T cells

KW - IFN-γ

KW - osteoclast

KW - osteoimmunology

KW - γδ T cells

U2 - 10.1111/cei.12165

DO - 10.1111/cei.12165

M3 - Article

VL - 174

SP - 281

EP - 291

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 2

ER -